Skip to main content
. 2021 Jan 5;22(1):443. doi: 10.3390/ijms22010443
ATMP Advanced therapy medicinal product
TMJ-OA Temporomandibular joint osteoarthritis
TMJ Temporomandibular joint
TMD Temporomandibular disorder
ABS Treatment group 1: AB Serum
HA Treatment group 2: Hyaluronic acid
STx. Treatment group 3: Mesenchymal stromal cells (Oxacells HP)
HA + STx. Treatment group 4: Hyaluronic acid + Mesenchymal stromal cells (Oxacells HP)
TMJD Temporomandibular joint disorders
RDC Research Diagnostic Criteria
TENS Transcutaneous electrical nerve stimulation
NSAID Non-steroidal anti-inflammatory drugs
PRP Platelet Rich Plasma
MSC Mesenchymal stromal cells
ESC Embryonic stromal cells
ISCT International Society for Cellular Therapy
ASC Adipose-derived stromal cells
SVF Stromal vascular fraction
BEI Back-scattered electron imaging
AC Articular cartilage
SMZ Subchondral mineralized zone
GAG Glycosaminoglycans
ADSC Adipose tissue-derived stromal cells
PDLSC Periodontal ligament stromal cells
SCAP Stromal cells from apical papilla
DFPC Dental follicle progenitor cells
DPSC Dental pulp stromal cells
MPC Mesenchymal progenitor cells
hMSC Human mesenchymal stromal cells
ACLT Anterior cruciate ligament transaction
PBS Phosphate-buffered saline
PMMA Polymethylmethacrylate